Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Tocilizumab
Tocilizumab
Routinely available
SMC (SMC2014)
27/03/2024
Indication
For the treatment of Giant Cell Arteritis (GCA) in adult patients.
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Routinely available in line with local or regional guidance
Formulation
162mg solution for injection in pre-filled syringe and pre-filled pen
Comments
Refer to pathway or local board guidelines for preferred formulation.